Intellia Therapeutics, Inc. (NTLA) by event type

NTLA moves most on analyst downgrades — a median of -2.02% at 30 minutes across 38 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the NTLA overview →

By event type

How NTLA reacts across 5 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
2,650 of 2,717
27-1.27%30%-0.33%
Analyst downgrades
2,531 of 2,603
38-2.02%37%-2.30%
Rating reiterations
1,096 of 3,522
147+0.06%54%-0.38%
Price-target raises
110 of 1,790
16+0.34%56%-2.53%
Price-target cuts
1,473 of 1,527
42-0.64%38%-0.12%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.

That’s how NTLA usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · Price-target cuts → · NTLA overview →

Other Healthcare names, measured the same way

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.